Global Biosimilars Market Size study, By Product (Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Enoxaparin Sodium, Glucagon, Calcitonin), By Indication (Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications), and Regional Forecasts 2023-2029
- Category: Healthcare
- Published Date: Dec 2022
- Publisher: Bizwit Research
- Pages: 125
The market study's purpose is to evaluate the global economy and its various segments in depth. The study's part on the business climate aids in a better understanding of worldwide competition for significant enterprises. The report looks at the global Biosimilars industry's market share, development potential, and opportunities. A brand analysis as well as demand mapping for various market situations are included in the study. A primary and secondary observational synthesis, as well as comments from market participants, were used in the research. The study presents an inclusive demand and an environment for dealers, in addition to assessing the sector's economic status.
Major Market players in Biosimilars Market are:
Samsung Biologics
Intas Pharmaceuticals Ltd.
Celltrion
Reliance Life Sciences
Pfizer, Inc.
Coherus BioSciences
Dr. Reddy’s Laboratories Ltd.
Amgen, Inc.
Biocon Limited
Apotex, Inc.
Key company executives present a complete overview and in-depth market analysis in this market research. The study highlights new global industry trends across diverse service providers. The market size, sales revenues, technical progress, expenditure, and potential are all covered in this report. The Biosimilars research report looks at service providers on a global basis and how they operate. Market share, scale, and growth variables, as well as significant players, are all investigated in this report.
Biosimilars Market Segmentation:
By Product
Monoclonal Antibodies
Insulin
Granulocyte Colony-Stimulating Factor
Erythropoietin
Recombinant Human Growth Hormone
Etanercept
Follitropin
Teriparatide
Interferons
Enoxaparin Sodium
Glucagon
Calcitonin
By Indication
Oncology
Inflammatory & Autoimmune Disorders
Chronic Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Indications
Regional Developments:
Porter's five forces analysis, a regional business environment assessment, market dynamics and drivers, opportunities and challenges, risk and entry barriers, and production and distribution networks are all included in the study. In addition, the fundamental purpose of this study is to look at the impact of a number of industrial elements on the market's future. The Biosimilars research report contains a detailed analysis of competitors, observations, and a quick look at possible competitors.
COVID-19 Impact Analysis:
During the main and secondary research phases, several industry experts and delegates are interviewed for a report on the Biosimilars market in order to provide clients with accurate information to solve market problems during and after the COVID-19 pandemic. This market research report includes a comprehensive analysis of market dynamics during the forecast period, as well as observations of key changes over time.
Competitive Scenario:
The study report also includes the predicted demand scale for each application. A quantitative assessment of the state of the market by registration, organisational structure, and geographical regions is included in the report's core analysis. Biosimilars research's purpose is to concentrate on worldwide market trends, opportunities, and current advancements. The study looks into the potential for regional development and provides a holistic view of a number of industries.
Report Answers Following Questions
- What are the most effective tactics for boosting a company's market share?
- Which regions will continue to be the most profitable regional marketplaces for Biosimilars market participants?
- What techniques may developed-region market enterprises employ to acquire a market competitive advantage?
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2023-2029(USD Billion)
1.2.1. Biosimilars Market, by Region, 2023-2029(USD Billion)
1.2.2. Biosimilars Market, by Product, 2023-2029(USD Billion)
1.2.3. Biosimilars Market, by Indication, 2023-2029(USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biosimilars Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biosimilars Market Dynamics
3.1. Biosimilars Market Impact Analysis (2023-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing geriatric population and the growing incidence of chronic diseases
3.1.1.2. Increasing demand for biosimilar drugs
3.1.2. Market Challenges
3.1.2.1. Complexities in manufacturing
3.1.3. Market Opportunities
3.1.3.1. Increasing investment for the introduction of new indications
Chapter 4. Global Biosimilars Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2023-2029)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Biosimilars Market, by Product
6.1. Market Snapshot
6.2. Global Biosimilars Market by Product, Performance - Potential Analysis
6.3. Global Biosimilars Market Estimates & Forecasts by Product, 2023-2029 (USD Billion)
6.4. Biosimilars Market, Sub Segment Analysis
6.4.1. Monoclonal Antibodies
6.4.2. Insulin
6.4.3. Granulocyte Colony-Stimulating Factor
6.4.4. Erythropoietin
6.4.5. Recombinant Human Growth Hormone
6.4.6. Etanercept
6.4.7. Follitropin
6.4.8. Teriparatide
6.4.9. Interferons
6.4.10. Enoxaparin Sodium
6.4.11. Glucagon
6.4.12. Calcitonin
Chapter 7. Global Biosimilars Market, by Indication
7.1. Market Snapshot
7.2. Global Biosimilars Market by Indication, Performance – Potential Analysis
7.3. Global Biosimilars Market Estimates & Forecasts by Indication, 2023-2029 (USD Billion)
7.4. Biosimilars Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Inflammatory & Autoimmune Disorders
7.4.3. Chronic Diseases
7.4.4. Blood Disorders
7.4.5. Growth Hormone Deficiency
7.4.6. Infectious Diseases
7.4.7. Other Indications
Chapter 8. Global Biosimilars Market, Regional Analysis
8.1. Biosimilars Market, Regional Market Snapshot
8.2. North America Biosimilars Market
8.2.1. U.S. Biosimilars Market
8.2.1.1. Product breakdown estimates & forecasts, 2023-2029
8.2.1.2. Indication breakdown estimates & forecasts, 2023-2029
8.2.2. Canada Biosimilars Market
8.3. Europe Biosimilars Market Snapshot
8.3.1. U.K. Biosimilars Market
8.3.2. Germany Biosimilars Market
8.3.3. France Biosimilars Market
8.3.4. Spain Biosimilars Market
8.3.5. Italy Biosimilars Market
8.3.6. Rest of Europe Biosimilars Market
8.4. Asia-Pacific Biosimilars Market Snapshot
8.4.1. China Biosimilars Market
8.4.2. India Biosimilars Market
8.4.3. Japan Biosimilars Market
8.4.4. Australia Biosimilars Market
8.4.5. South Korea Biosimilars Market
8.4.6. Rest of Asia Pacific Biosimilars Market
8.5. Latin America Biosimilars Market Snapshot
8.5.1. Brazil Biosimilars Market
8.5.2. Mexico Biosimilars Market
8.6. Rest of The World Biosimilars Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Samsung Biologics
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Intas Pharmaceuticals Ltd.
9.2.3. Celltrion
9.2.4. Reliance Life Sciences
9.2.5. Pfizer, Inc.
9.2.6. Coherus BioSciences
9.2.7. Dr. Reddy’s Laboratories Ltd.
9.2.8. Amgen, Inc.
9.2.9. Biocon Limited
9.2.10. Apotex, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption